Fidelity Top Stories
GlaxoSmithKline stands by full-year EPS guidance but with a caveat
GlaxoSmithKline saw its top line shrink over the second quarter, somewhat ironically as the Covid-19 pandemic disrupted its vaccines unit.
Barclays increases Covid-19 provisions as profits plunge
Barclays raised its provisions for coronavirus-related bad debts by £1. 6bn in the second quarter as interim profits slumped and the bank forecast further headwinds into 2021.
Petropavlovsk shareholders set for battle over control of miner
Shareholders in Russian miner Petropavlovsk are trying to mobilise investors to vote in an upcoming emergency meeting against what they claim is an attempt to take over the company by stealth.
Heathrow chief calls on UK government to introduce passenger Covid-19 tests
The chief executive of Heathrow airport asked the UK government on Wednesday to urgently introduce passenger testing after reporting a 96% fall in passenger numbers during the second quarter.
UK lending to individuals and mortgage approvals stronger than expected in June
Lending to individuals began to bounce back in June alongside a stronger than expected pace of mortgage approvals.
Aston Martin losses widen on weak sales but signs of China recovery
Losses at luxury carmaker Aston Martin widened in the first half as Covid-related factory closures hit already-struggling sales, although there were signs of a recovery in China during June.
Rio Tinto pays dividend as iron ore prices soar
Soaring iron ore prices and better-than-expected interim profits allowed mining giant Rio Tinto to pay out a dividend.
Sanofi and GSK to provide UK with 60m doses of Covid-19 vaccine
French pharmaceutical giant Sanofi and GlaxoSmithKline have agreed to provide the UK with as many as 60. 0m doses of their Covid-19 vaccine candidate, subject to final contract.